Ochratoxin A (OTA): Produced by Aspergillus and Penicillium species, OTA is nephrotoxic (kidney-damaging), immunosuppressive, and has been detected in human blood, breast milk, and urine
For ultra-orphan drugs at prices of $300,000 to $500,000 per patient year, seven years of exclusivity on a 3,000-patient market can generate more than $1 billion in cumulative revenue
Drug interactions include potential effects on oral medication absorption due to delayed gastric emptying
Key Ingredients: L-Carnitine (20g/10ml): A naturally occurring amino acid derivative that plays a critical role in the transport of fatty acids into the mitochondria, where they are converted into energy
Its safety and tolerability profiles are consistent with other GLP-1RA class therapies
Its a best practice to keep vials in their box or in a dark part of the refrigerator to protect them.